China Universal Asset Management Co., Ltd. Entrada Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 7,541 shares of TRDA stock, worth $38,911. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,541
Previous 7,931
4.92%
Holding current value
$38,911
Previous $137,000
50.36%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TRDA
# of Institutions
107Shares Held
28.8MCall Options Held
15.7KPut Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$25.1 Million0.33% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$22.6 Million67.92% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.31MShares$22.2 Million19.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.57MShares$13.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$8.74 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $162M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...